-
Covid jab rivals face off in court as Moderna sues Pfizer and BioNTech for 'infringing on its patent' for life-saving mRNA vaccines
23 Apr 2024 18:01 GMT
… vaccine technology's patent.
Pharmaceutical giant Pfizer and … its Covid-19 related patents while the pandemic continued. … partner BioNTech for alleged patent infringement in relation to … ;BioNTech and Oxford/AstraZeneca vaccines were approved.
How the …
-
Global Diabetes Drugs Market to Witness an Upsurge in Growth by 2030, Examines DelveInsight | Key Companies in the Market - Sanofi, AstraZeneca, Pfizer, Johnson & Johnson, Novartis, Merck & Co., Novo Nordisk, Eli Lilly and Company, Biocon
23 Apr 2024 17:00 GMT
…
Key Diabetes Drugs Companies
Sanofi, AstraZeneca, Pfizer, Johnson & Johnson, … Executive summary
3
Regulatory and Patent Analysis
4
Key Factors Analysis … , Precigen, Inc., Japan Tobacco, Avotres, AstraZeneca, Landos Biopharma, Vertex Pharmaceuticals, REMD …
-
AstraZeneca gets grant for inhibitors of complement factor d for treating disorders
23 Apr 2024 15:21 GMT
… innovation area identified from patents. AstraZeneca's grant share … of patents.
Source: United States Patent and Trademark Office (USPTO). Credit: AstraZeneca … Plc
A recently granted patent …
-
Rival Covid-19 jab developers face off in High Court patent trial
23 Apr 2024 12:46 GMT
… life-saving vaccine technology patents began.
Pharmaceutical giant … partner BioNTech for alleged patent infringement in relation … “revocation” of two Moderna patents, claiming that they are … BioNTech and Oxford/AstraZeneca vaccines were approved.
How …
-
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO
23 Apr 2024 20:49 GMT
… it becomes law.
Meanwhile, AstraZeneca, for whom China is … States and Europe independently,” AstraZeneca CEO Pascal Soriot said … mechanisms for patent disputes to include more patent types. He … accelerate the implementation of patent compensation for new drugs. …
-
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
23 Apr 2024 19:40 GMT
… growth outlook is robust.
AstraZeneca reported double-digit earnings growth … At the same time, AstraZeneca is well diversified across geographies … several blockbuster drugs going off-patent in the coming years, … impact of drugs going off-patent.
On the date of …
-
Baron Health Care Fund Q1 2024 Shareholder Letter
23 Apr 2024 14:48 GMT
… growth prospects and upcoming patent expirations. The Fund also … of the scheduled expiration of patent protection/exclusivity rights … long-term outlook. We reduced AstraZeneca PLC (AZN)(OTCPK:AZNCF) … Index. Russell® is a trademark of the relevant LSE Group …
-
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
22 Apr 2024 20:30 GMT
… advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG … ® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics …
-
Cytonus Therapeutics Expands C-suite as it Transitions to a Clinical Stage Company
22 Apr 2024 19:14 GMT
… a member of MedImmune/AstraZeneca's Partnering & Strategy … wealth of experience as a patent leader fostering the success of …
-
India’s difficult business environment is improving
22 Apr 2024 13:03 GMT
… giant pharmaceutical companies, such as AstraZeneca, as well as cultural icons … more innovative. A study by PatentVector, an analytics firm, showed the … valuation of Indian patents has more than tripled over …